NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Advaxis, Inc. (NASDAQ: ADXS) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Biosight Ltd.

Click

here

to learn more and participate in the action.

On July 6, 2021, Advaxis announced that it had signed an agreement to merge with Biosight in an all-stock transaction. Pursuant to the merger agreement, at the close of the merger Advaxis stockholders will own approximately 25% of the combined company. The deal is scheduled to close in the second half of 2021.

Bragar Eagel & Squire is concerned that Advaxis’ board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Advaxis’ stockholders.

If you own shares of Advaxis and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at

[email protected]

or telephone at (646) 860-9157, or by

filling out this contact form

. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:


Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit


www.bespc.com


. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:


Bragar Eagel & Squire, P.C.

Melissa Fortunato, Esq.

Alexandra Raymond, Esq.



[email protected]





www.bespc.com